Sanofi Pasteur Inc., a foreign-owned pharmaceutical manufacturer, holds a multiple award Federal Supply Schedule (FSS-61-IB) contract for Pharmaceuticals and Drugs valued at $634 million with the Department of Veterans Affairs. Under this IDV, Sanofi Pasteur has received numerous task orders to provide a range of vaccines and pharmaceutical products to federal civilian and defense agencies, including the Department of Veterans Affairs, Indian Health Service, Department of State, Department of the Army, and Smithsonian Institution. The products delivered include seasonal and pandemic influenza vaccines, pneumonia vaccines, meningitis vaccines, respiratory syncytial virus (RSV) vaccines, polio virus vaccine, tetanus toxoid vaccine, typhoid vaccine, and other standard immunizations. The firm fixed price task orders, many in the millions of dollars, support public health preparedness, disease prevention, and medical countermeasures for these agencies. Performance primarily occurs at Sanofi Pasteur's facilities in Pennsylvania and Virginia, without any set-aside designations.
Sanofi Pasteur's extensive experience and capabilities in vaccine manufacturing and distribution make it a trusted provider of pharmaceutical products to the federal government. The company holds several other IDVs, including a $5.87 billion IDIQ contract with the HHS Office of the Assistant Secretary for Preparedness and Response to supply medical countermeasures. These contract vehicles enable streamlined ordering and fulfillment of agency requirements for critical vaccines and drugs to support public health missions across civilian and defense agencies.
Generated 1/1/25, 9:05 AM